MWNA
BNTX icon

Marshall Wace North America’s BioNTech BNTX Stock Holding History

Marshall Wace North America’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-1,312
Closed -$294K – 1445
2021
Q2 		$294K Buy
+1,312
New +$247K ﹤0.01% 1288
2020
Q3 		– Sell
-17,428
Closed -$1.16M – 1220
2020
Q2 		$1.16M Buy
+17,428
New +$870K 0.01% 723

Other funds holding BNTX

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FI
Fosun International Hong Kong, China $446M AUM 13.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PG
Pendal Group Sydney, Australia $11.6B AUM 12.87% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return

Marshall Wace North America's BNTX Position: Q3 2021 in Review

Marshall Wace North America sold out of BioNTech (BNTX) in Q3 2021, closing a stake of 1,312 shares — an estimated $294K sold.

Marshall Wace North America first reported a position in BNTX in Q2 2020 and held it in 2 quarters. The position peaked at $1.16M in Q2 2020. 336 funds tracked by Wall St. Rank hold BNTX as of Q3 2021.

  • Marshall Wace North America reported no remaining BioNTech position as of Q3 2021 after selling out during the quarter.
  • Marshall Wace North America sold 1,312 BioNTech shares in Q3 2021, an estimated $294K.
  • Marshall Wace North America first reported a position in BioNTech in Q2 2020 and held it in 2 quarters.
  • Marshall Wace North America's BioNTech position peaked at $1.16M in Q2 2020.
  • 336 funds tracked by Wall St. Rank held BioNTech as of Q3 2021.

Based on Marshall Wace North America's 13F filing for Q3 2021, filed 15 Nov 2021.